Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > More Insider activity.
View:
Post by jh1970 on Dec 20, 2024 6:50pm

More Insider activity.

 
led 2024-12-20 17:09
Tx date 2024-12-18

 

 
$ONC
Oncolytics Biotech Inc.
 
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
 
Options
50 - Grant of options
 
$275,268
+243,600 vol
$1.13 each
 
950,720
 
Filed 2024-12-20 17:07
Tx date 2024-12-18

 

 
$ONC
Oncolytics Biotech Inc.
 
Coffey, Matthew
4 - Director of Issuer
5 - Senior Officer of Issuer
Direct Ownership
 
Rights Restricted Share Units
56 - Grant of rights
 
+138,838 vol
 
255,171
 
Filed 2024-12-20 17:06
Tx date 2024-12-18

 

 
$ONC
Oncolytics Biotech Inc.
 
Coffey, Matthew
4 - Director of Issuer
5 - Senior Officer of Issuer
Direct Ownership
 
Options
50 - Grant of options
 
$231,763
+205,100 vol
$1.13 each
 
1,560,468
Comment by canadafan on Dec 20, 2024 8:26pm
I'm not an insider. I did mention yesterday my thoughts of buying more. slept on it. today m I increased my share count by 30%. Why? fisrt the sp is beyond silly low. Second, the recent announcement of yet another cancer treatment update to be reported at the upcoming symposium. Yet another development alongside Roche. Third The massive buying Thursday was clearly institutional. My ...more  
Comment by laroplex on Dec 21, 2024 10:25am
Canadafan that is great for you, increase your share count another 30%....To be honest i've been doing the same, regaedless of my venting the other day....I got lucky i was able to pick some more up at $1.04 on Thursday around 10'ish in the morning...then BOOM, she went upward hard and fast, deep pocket buying.....I got my even low single 6 digit amount of shares....Now it's a waiting ...more  
Comment by Peladawn on Dec 21, 2024 2:16pm
laroplex....6 digits!...nice!.....you are going to pretty uh.......comfortable!......you might wanna make sure you put all those shares up for sale on a super high, good til close order.....so the mms can't use your shares to short....mind you,..I've got some more dry powder coming about the middle of January.....I hope they drive it down to .50 by, then.....lol....I'm not worried ...more  
Comment by venture009 on Dec 22, 2024 9:43pm
They haven't exercised. When they exercise we'll see that they have some skin in the game until then not much has changed.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities